Classifying Cytogenetics in Patients with AML in Complete Remission Undergoing Allogeneic Transplantation: A CIBMTR Study

Cytogenetics play a major role in determining the prognosis of patients with AML. However, the existing cytogenetics classifications were developed on chemotherapy-treated patients and may not be optimal for patients undergoing allogeneic hematopoietic cell transplantation (HCT). We studied 821 adul...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Armand, Philippe, Kim, Haesook T., Zhang, Mei-Jie, Perez, Waleska S., Dal Cin, Paola S., Klumpp, Thomas R., Waller, Edmund K., Litzow, Mark R., Liesveld, Jane L., Lazarus, Hillard M., Artz, Andrew S., Gupta, Vikas, Savani, Bipin N., McCarthy, Philip L., Cahn, Jean-Yves, Schouten, Harry C., Finke, Jürgen, Ball, Edward D., Aljurf, Mahmoud D., Cutler, Corey S., Rowe, Jacob M., Antin, Joseph H., Isola, Luis M., Di Bartolomeo, Paolo, Camitta, Bruce M., Miller, Alan M., Cairo, Mitchell S., Stockerl-Goldstein, Keith, Sierra, Jorge, Savoie, M. Lynn, Halter, Joerg, Stiff, Patrick J., Nabhan, Chadi, Jakubowski, Ann A., Bunjes, Donald W., Petersdorf, Effie W., Devine, Steven M., Maziarz, Richard T., Bornhauser, Martin, Lewis, Victor A., Marks, David I., Bredeson, Christopher N., Soiffer, Robert J., Weisdorf, Daniel J.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2011
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3224672/
https://ncbi.nlm.nih.gov/pubmed/21810400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2011.07.024
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים